U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387588) titled 'Anemia as Predictor of Outcome in IBD Pateints in Assuit University Hospitals' on Jan. 28.
Brief Summary: Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), are chronic, relapsing inflammatory disorders of the gastrointestinal tract with significant morbidity and impact on patients' quality of life. Despite advances in diagnostic and therapeutic strategies, many patients continue to experience complications, frequent hospitalizations, and impaired long-term outcomes. Identifying prognostic factors that can predict disease course and response to therapy is therefore crucial in guiding cli...